|

Paclitaxel Polymeric Micelles for Injection Clinical Trials

2 actively recruiting trials

▼ -1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Shanghai Yizhong Pharmaceutical Co., Ltd.1
  • Liu Huang1

Indications

  • Cancer2
  • Esophageal Carcinoma1
  • Pancreatic Cancer Metastatic1
  • Cholangiocarcinoma1
  • Stomach Cancer1

Other2 trials

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Phase 2
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.